3FMA Stock Overview
Provides aesthetic medical services in the People’s Republic of China and Singapore. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
Aesthetic Medical International Holdings Group Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$0.21 |
| 52 Week High | US$0.63 |
| 52 Week Low | US$0.10 |
| Beta | -0.084 |
| 11 Month Change | 10.88% |
| 3 Month Change | 32.10% |
| 1 Year Change | -62.46% |
| 33 Year Change | -92.67% |
| 5 Year Change | n/a |
| Change since IPO | -95.14% |
Recent News & Updates
Recent updates
Shareholder Returns
| 3FMA | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 0.9% | 0.2% | 0.8% |
| 1Y | -62.5% | 13.9% | 8.6% |
Return vs Industry: 3FMA underperformed the German Healthcare industry which returned 17.4% over the past year.
Return vs Market: 3FMA underperformed the German Market which returned 9.1% over the past year.
Price Volatility
| 3FMA volatility | |
|---|---|
| 3FMA Average Weekly Movement | 49.7% |
| Healthcare Industry Average Movement | 4.0% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.9% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 3FMA's share price has been volatile over the past 3 months compared to the German market.
Volatility Over Time: 3FMA's weekly volatility (50%) has been stable over the past year, but is still higher than 75% of German stocks.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1997 | 1,286 | n/a | ir.aihgroup.net |
Aesthetic Medical International Holdings Group Limited provides aesthetic medical services in the People’s Republic of China and Singapore. The company offers surgical aesthetic treatments, such as eye surgery, rhinoplasty, breast augmentation, and liposuction; and non-surgical aesthetic treatments, including minimally invasive and energy-based treatments, which include laser, ultrasound, and radiofrequency treatments. It also provides general healthcare and other aesthetic medical services, such as internal medicine, urology, gynecology, and obstetrics treatment services, as well as dentistry, dermatology, and hair loss treatment services.
Aesthetic Medical International Holdings Group Limited Fundamentals Summary
| 3FMA fundamental statistics | |
|---|---|
| Market cap | €11.41m |
| Earnings (TTM) | -€6.39m |
| Revenue (TTM) | €95.90m |
0.1x
P/S Ratio-1.8x
P/E RatioIs 3FMA overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3FMA income statement (TTM) | |
|---|---|
| Revenue | CN¥726.67m |
| Cost of Revenue | CN¥396.84m |
| Gross Profit | CN¥329.82m |
| Other Expenses | CN¥378.24m |
| Earnings | -CN¥48.42m |
Last Reported Earnings
Jun 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -1.01 |
| Gross Margin | 45.39% |
| Net Profit Margin | -6.66% |
| Debt/Equity Ratio | 1,285.9% |
How did 3FMA perform over the long term?
See historical performance and comparison